Trinity biotech plc (TRIB)
Income statement / Quarterly
Jun'18Jun'17
Revenues

25,002

25,448

Cost of sales

14,194

14,629

Gross profit

10,808

10,819

Other operating income

24

26

Research & development expenses

1,419

1,322

Selling, general and administrative expenses

7,358

7,561

Indirect share based payments

329

130

Operating profit

1,726

1,832

Financial income

196

196

Financial expenses

1,158

1,169

Net financing expense

-962

-973

Profit before tax & non-cash items

764

859

Income tax expense

158

176

Profit after tax before non-cash items

606

683

Non-cash financial (expense) / income

-12

219

Profit after tax and non-cash items

594

902

Earnings per ADR (US cents)

2.80

4.10

Earnings per ADR excluding non-cash financial (expense) / income (US cents)

2.90

3.10

Diluted earnings per ADR (US cents)

6.70

6.80

Weighted average no. of ADRs used in computing basic earnings per ADR

20,901

21,847

Weighted average no. of ADRs used in computing diluted earnings per ADR

26,157

27,104